RECRUITING

Virtual Reality 3D-Surgery Modeling to Enhance Head and Neck Cancer Surgery Quality

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This clinical trial studies the use of virtual reality technology and three dimensional surgery (3D-surgery) modeling to enhance current treatments in head and neck cancer surgery. Virtual reality 3D-surgery modeling may improve quality of surgical planning and interdisciplinary communication between surgeons and pathologists during the treatment of head and neck squamous cell cancer and ultimately increase the accuracy of planning, the quality of communication, and maximize the outcome patients with head and neck cancer experience throughout treatment.

Official Title

Preoperative Virtual Reality and 3D Pathologic Modeling as Treatment for Head and Neck Squamous Cell Carcinoma

Quick Facts

Study Start:2022-02-04
Study Completion:2027-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05031910

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosed with cancer of the head and neck (oral cavity, oropharynx, larynx, hypopharynx, T1-T4)
  2. * Receiving treatment at Thomas Jefferson University - Center City by a fellowship-trained HNC surgeon
  3. * Eligible for definitive resection
  4. * Age \> 18
  5. * Provide signed written informed consent document
  1. * Impaired judgement or those unable to provide informed consent
  2. * Any factor that would place the patient at increased risk or preclude the individual's full compliance with or completion of the study
  3. * Nasopharyngeal carcinoma
  4. * Contraindications for surgery
  5. * Enrollment in other clinical trial

Contacts and Locations

Study Contact

Joseph Curry, MD
CONTACT
215-955-6784
joseph.curry@jefferson.edu

Study Locations (Sites)

Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, 19107
United States

Collaborators and Investigators

Sponsor: Thomas Jefferson University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-02-04
Study Completion Date2027-05

Study Record Updates

Study Start Date2022-02-04
Study Completion Date2027-05

Terms related to this study

Additional Relevant MeSH Terms

  • Head and Neck Squamous Cell Carcinoma